Minerva Neurosciences (NERV) Non-Current Deffered Revenue (2017 - 2020)

Minerva Neurosciences (NERV) has 4 years of Non-Current Deffered Revenue data on file, last reported at $41.2 million in Q1 2020.

• Quarterly Non-Current Deffered Revenue changed 0.0% year-over-year to $41.2 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $41.2 million (changed 0.0% YoY) and the FY2019 annual result came in at $41.2 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue was little changed at $41.2 million in Q1 2020, from $41.2 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $41.2 million in Q3 2017 to a low of $41.2 million in Q3 2017.
• A 4-year average of $41.2 million and a median of $41.2 million in 2017 frame the typical range for Non-Current Deffered Revenue.
• The widest YoY moves for Non-Current Deffered Revenue: up 0.0% in 2018, down 0.0% in 2018.
• Tracing NERV's Non-Current Deffered Revenue over 4 years: stood at $41.2 million in 2017, then changed by 0.0% to $41.2 million in 2018, then changed by 0.0% to $41.2 million in 2019, then changed by 0.0% to $41.2 million in 2020.
• The last three Non-Current Deffered Revenue figures came in at $41.2 million (Q1 2020), $41.2 million (Q4 2019), and $41.2 million (Q3 2019), per Business Quant data.